We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bacterial Cytological Profiling Streamlines Search for New Antibiotics

By LabMedica International staff writers
Posted on 22 Dec 2015
Bacterial cytological profiling is a rapid screening technique for identifying and characterizing new antibiotic compounds from mixtures of natural products.

Although most clinically used antibiotics are derived from natural products, identifying new antibacterial molecules from natural product extracts is difficult due to the complexity of these extracts and the limited tools to correlate biological activity with specific molecules.

Investigators at the University of California, San Diego (USA) have demonstrated that bacterial cytological profiling (BCP) was a rapid method for determining mechanism of antibiotic action on plates and in complex natural product extracts and for activity-guided purification.

They reported in the December 9, 2015, online edition of the Journal of Antibiotics that they had prepared an extract from Bacillus subtilis 3610 that killed the Escherichia coli lptD mutant and that they had used BCP to observe two types of bioactivities in the unfractionated extract: inhibition of translation and permeablization of the cytoplasmic membrane. More...


The investigators used BCP to guide purification of the molecules responsible for each activity, identifying the translation inhibitors bacillaene and bacillaene B (glycosylated bacillaene) and demonstrating that two molecules contributed to cell permeabilitization, the bacteriocin subtilosin and the cyclic peptide sporulation killing factor.

The investigators also showed that BCP could be used to screen strains on an agar plate without the need for extract preparation, greatly saving time and improving throughput.

"We have now shown that our method is a powerful way to identify antibiotics from natural products and understand how they work before they are ever purified, potentially shaving years off of screening efforts by identifying which organisms and growth conditions produce interesting bioactive molecules," said senior author Dr. Kit Pogliano, professor of biology at the University of California, San Diego. "This method is a powerful tool for identifying new compounds from sources of natural products that kill bacteria and for determining how they work. Some bacteria have evolved resistance to every known class of antibiotic and, when these multidrug resistant bacteria cause an infection, they are nearly impossible to treat. There is an urgent need for new antibiotics capable of treating infections caused by antibiotic resistant bacteria. With our new method, we can determine which strain is producing an interesting activity and then follow that specific activity during purification to make sure we purify the right molecule. This new approach will help to open up the discovery pipeline, allowing more potential antibiotic producing strains to be rapidly screened for antibiotics that are active against multidrug resistant bacterial pathogens."

Related Links:

University of California, San Diego



New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.